Skip to main content

The Ins and Outs of Clinical Trials

  • Chapter
  • First Online:
Women in Ophthalmology
  • 308 Accesses

Abstract

Success as a clinical trials investigator requires medical expertise in the disease being studied, expertise in regulations surrounding human research, and meticulous compliance with study protocols and procedures. Knowledge of the disease being investigated empowers the investigator to ask questions that address unmet needs for that specific disease. The investigator must be familiar with the regulations surrounding human research in order to know whether he or she is in compliance with those requirements. The investigator must be ethical, unbiased, organized, and focused on details. A successful clinical trial results from team effort, and the principal investigator must me a motivating leader. Results of clinical trials are valid only if the subjects are appropriately selected to comply with inclusion criteria, the protocol is followed strictly, and the data is analyzed using relevant statistical methods. This chapter focuses upon these facets of becoming a successful clinical trials investigator.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ClinicalTrials.gov. Spectri lampalizumab study page. https://clinicaltrials.gov/ct2/show/NCT02247531.

  2. ClinicalTrials.gov. Chroma lampalizumab study page. https://clinicaltrials.gov/ct2/show/NCT02247479.

  3. https://about.citiprogram.org/en/homepage.

  4. www.hhs.gov/ohrp/regulations.

  5. www.ecfr.gov/cgi-bin/retrieveECFR.

  6. Protection of human subjects; Belmont report: notice of report for public comment. Fed Regist. 1979;44(76):23191–7.

    Google Scholar 

  7. Byerly WG. Working with the institutional review board. Am J Health Syst Pharm. 2009;66(2):176–84.

    Article  Google Scholar 

  8. Zhou B, Mitchell TC, Rusakevich AM, Brown DM, Wykoff CC. Noncompliance in prospective retina clinical trials: analysis of factors predicting loss to follow up. Am J Ophthalmol. 2020;210:86–96.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lim, J.I. (2021). The Ins and Outs of Clinical Trials. In: Weng, C.Y., Berrocal, A.M. (eds) Women in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-59335-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-59335-3_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-59334-6

  • Online ISBN: 978-3-030-59335-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics